Industrial and Commercial Bank of China Limited (1398.HK) vs Merck & Co., Inc. (MRK)

Industrial and Commercial Bank of China Limited is one of China’s largest state-controlled commercial banks. It provides corporate banking, personal banking, wealth management, payments, and treasury services through a broad domestic and international network. The bank serves major companies, public-sector entities, small businesses, and retail customers. Its results are influenced by Chinese credit growth, interest-rate spreads, asset quality, government policy, and the health of the country’s property, infrastructure, and industrial sectors.

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.